1 / 11

Aarkstore - Dry (Atrophic) Macular Degeneration - Pipeline R

“Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014”, provides an overview of the Dry (Atrophic) Macular Degeneration’s therapeutic pipeline. For more details : http://goo.gl/TsSoQG

Shubhangi
Download Presentation

Aarkstore - Dry (Atrophic) Macular Degeneration - Pipeline R

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aarkstore - Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014 www.aarkstore.com

  2. Summary “Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014”, provides an overview of the Dry (Atrophic) Macular Degeneration’s therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Dry (Atrophic) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dry (Atrophic) Macular Degeneration and special features on late-stage and discontinued projects. www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Dry (Atrophic) Macular Degeneration- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Dry (Atrophic) Macular Degeneration and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Dry (Atrophic) Macular Degeneration products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Dry (Atrophic) Macular Degeneration- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Dry (Atrophic) Macular Degeneration pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com

  5. Table of Contents Introduction 8Global Markets Direct Report Coverage 8Dry (Atrophic) Macular Degeneration Overview 9Therapeutics Development 10Pipeline Products for Dry (Atrophic) Macular Degeneration - Overview 10Pipeline Products for Dry (Atrophic) Macular Degeneration - Comparative Analysis 11Dry (Atrophic) Macular Degeneration - Therapeutics under Development by Companies 12Dry (Atrophic) Macular Degeneration - Therapeutics under Investigation by Universities/Institutes 14Dry (Atrophic) Macular Degeneration - Pipeline Products Glance 15Late Stage Products 15Clinical Stage Products 16Early Stage Products 17Unknown Stage Products 18 www.aarkstore.com

  6. List Of Tables Number of Products under Development for Dry (Atrophic) Macular Degeneration, H2 2014 10Number of Products under Development for Dry (Atrophic) Macular Degeneration - Comparative Analysis, H2 2014 11Number of Products under Development by Companies, H2 2014 13Number of Products under Investigation by Universities/Institutes, H2 2014 14Comparative Analysis by Late Stage Development, H2 2014 15Comparative Analysis by Clinical Stage Development, H2 2014 16Comparative Analysis by Early Stage Development, H2 2014 17Comparative Analysis by Unknown Stage Development, H2 2014 18Products under Development by Companies, H2 2014 19Products under Development by Companies, H2 2014 (Contd..1) 20 www.aarkstore.com

  7. List Of Figures Number of Products under Development for Dry (Atrophic) Macular Degeneration, H2 2014 10Number of Products under Development for Dry (Atrophic) Macular Degeneration - Comparative Analysis, H2 2014 11Number of Products under Development by Companies, H2 2014 12Comparative Analysis by Clinical Stage Development, H2 2014 16Comparative Analysis by Early Stage Products, H2 2014 17Assessment by Monotherapy Products, H2 2014 40Number of Products by Top 10 Targets, H2 2014 41Number of Products by Stage and Top 10 Targets, H2 2014 42Number of Products by Top 10 Mechanism of Actions, H2 2014 43Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 43 www.aarkstore.com

  8. Related Market Research reports: • Blirt S.A. - Product Pipeline Review – 2014 • Auris Medical Holding AG - Product Pipeline Review – 2014 • Integral Molecular, Inc. - Product Pipeline Review – 2014 • DaVinci Biosciences, LLC - Product Pipeline Review – 2014 • Actavis plc - Product Pipeline Review - 2014 www.aarkstore.com

  9. Related Market Research reports: • TiGenix NV - Product Pipeline Review – 2014 • Egenix, Inc. - Product Pipeline Review – 2014 • SkyePharma PLC - Product Pipeline Review – 2014 • MediWound Ltd. - Product Pipeline Review – 2014 • BioTech Tools s.a. - Product Pipeline Review - 2014 www.aarkstore.com

  10. Aarkstore - Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014 www.aarkstore.com

  11. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com

More Related